VJHemOnc Podcast Recent updates in CML: treatment strategies, clinical trials, and novel agents
Nov 11, 2022
Experts Jorge Cortes and Mhairi Copland discuss recent updates in chronic myeloid leukemia (CML), including treatment strategies for refractory disease, novel agents, and clinical trial updates from the OPTIC and ASCEMBL trials. They highlight the use of new drugs and optimized doses, personalized approaches, and the potential of combining TKI therapy with immunological approaches for improved responses in CML patients.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Optimizing the starting dose of panatinib in patients with prior tyrosine kinase inhibitors
01:43 • 2min
Treatment strategies, personalized approaches, and options for CML patients
04:11 • 3min
Combining Panatine with Flagide Ecumen Therapy for Leukemia Treatment
07:35 • 3min
Treatment Strategies and Clinical Trials for Chronic Myeloid Leukemia (CML)
10:12 • 6min